SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001069530-22-000011
Filing Date
2022-03-01
Accepted
2022-02-28 17:32:53
Documents
80
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sava-20211231x10k.htm   iXBRL 10-K 3763579
2 EX-10.1 sava-20211231xex10_1.htm EX-10.1 140911
3 EX-21.1 sava-20211231xex21_1.htm EX-21.1 4209
4 EX-23.1 sava-20211231xex23_1.htm EX-23.1 11052
5 EX-31.1 sava-20211231xex31_1.htm EX-31.1 21448
6 EX-31.2 sava-20211231xex31_2.htm EX-31.2 21838
7 EX-32.1 sava-20211231xex32_1.htm EX-32.1 11895
8 GRAPHIC sava-20211231x10kg001.jpg GRAPHIC 28862
9 GRAPHIC sava-20211231x10kg002.jpg GRAPHIC 30381
10 GRAPHIC sava-20211231x10kg003.jpg GRAPHIC 23294
11 GRAPHIC sava-20211231x10kg004.jpg GRAPHIC 31851
12 GRAPHIC sava-20211231x10kg005.jpg GRAPHIC 93477
13 GRAPHIC sava-20211231x10kg006.jpg GRAPHIC 56108
14 GRAPHIC sava-20211231x10kg007.jpg GRAPHIC 61209
15 GRAPHIC sava-20211231x10kg008.jpg GRAPHIC 52170
16 GRAPHIC sava-20211231x10kg009.jpg GRAPHIC 36864
17 GRAPHIC sava-20211231xex10_1g001.jpg GRAPHIC 13428
  Complete submission text file 0001069530-22-000011.txt   8381494

Data Files

Seq Description Document Type Size
18 EX-101.SCH sava-20211231.xsd EX-101.SCH 37731
19 EX-101.CAL sava-20211231_cal.xml EX-101.CAL 53278
20 EX-101.DEF sava-20211231_def.xml EX-101.DEF 144872
21 EX-101.LAB sava-20211231_lab.xml EX-101.LAB 362567
22 EX-101.PRE sava-20211231_pre.xml EX-101.PRE 321117
74 EXTRACTED XBRL INSTANCE DOCUMENT sava-20211231x10k_htm.xml XML 305653
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29959 | Film No.: 22691858
SIC: 2834 Pharmaceutical Preparations